A novel medication, Retatrutide , is sparking considerable buzz amongst clinicians and individuals in Australia struggling with obesity . Created by Eli Lilly , Retatrutide operates as a dual GIP and GLP-1 https://retaaustralia945350.mindblogling.com/62053448/this-hope-for-aussie-citizens-with-excess-weight